Updates on denosumab discountinuation

Created using ChatSlide

Join us for a compelling keynote where we delve into the insights on Denosumab, a crucial monoclonal antibody used in osteoporosis management. The presentation explores its effectiveness on bone mineral density, the challenges of treatment cessation including bone turnover rebound and fracture risks, and discusses strategies for safe discontinuation. We'll examine international guidelines and present case studies that offer data-driven insights. Finally, we'll weigh long-term use benefits...